ニュース
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...
2 日
MyChesCo on MSNFDA Announces Ambitious AI Expansion to Streamline Scientific ReviewsThe U.S. Food and Drug Administration (FDA) has unveiled a historic initiative to implement artificial intelligence (AI) ...
Read about the House Energy and Commerce Committee's budget text, which includes funding for Commerce's federal IT ...
アメリカ食品医薬品局には、市販薬と処方薬の審査を担当する部局として「医薬品評価研究センター (CDER)」という部署があり、「cderGPT」という名称はCDERから取られたものと考えられます。 Center for Drug Evaluation ...
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
| Medrio CEO Nicole Latimer discusses strategiesthe company’s mission to streamline clinical trials, embrace meaningful ...
Q1 2025 Results Conference Call May 5, 2025 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations, Gilmartin ...
Next time you see your family physician or a hospital doctor, be extra kind and patient -- they could be on the verge of ...
Baron Fifth Avenue Growth Fund declined during the first quarter of 2025, underperforming its benchmark, the Russell 1000 ...
5 日
Axios on MSNAxios Event: Biopharma must pivot on funding sources amid federal research cuts, experts sayUpheaval in Washington is creating an unpredictable path forward for innovation and investment in the biopharmaceutical ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する